The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 28, 2018

Filed:

Apr. 05, 2013
Applicant:

Gottfried Himmler, Vienna, AT;

Inventor:

Gottfried Himmler, Vienna, AT;

Assignee:

Other;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/44 (2006.01); C07K 16/04 (2006.01); C07K 16/12 (2006.01); C07K 16/30 (2006.01); A61K 39/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/44 (2013.01); C07K 16/04 (2013.01); C07K 16/1282 (2013.01); C07K 16/3076 (2013.01); A61K 38/00 (2013.01); A61K 2039/541 (2013.01); C07K 2317/14 (2013.01); C07K 2317/30 (2013.01); C07K 2317/31 (2013.01); C07K 2317/40 (2013.01); C07K 2317/41 (2013.01); C07K 2319/036 (2013.01);
Abstract

The invention provides a method of producing an immune complex preparation based on a secretory immunoglobulin, which is non-human secretion derived, comprising providing an industrial scale production system, capable of producing an N-glycosylated Secretory Component, producing by such system a Secretory Component comprising at least 0.01 mol non-core fucose per mol Secretory Component, and combining said Secretory Component with at least one of IgA or IgM immunoglobulins having a native glycosylation pattern to obtain an immune complex. The invention provides an isolated recombinant Secretory Component comprising the amino acid sequence of SEQ ID 1, or a functionally active variant thereof, which has a Lewis-type N-glucosylation pattern and at least 2 mol non-core fucose per mol Secretory Component; and an immune complex preparation based on a secretory immunoglobulin, derived from sources other than human secretions, comprising a Secretory Component with a Lewis-type N-glucosylation pattern and at least 0.01 mol non-core fucose per mol Secretory Component, and at least one of IgA or IgM immunoglobulins having a native glycosylation pattern.


Find Patent Forward Citations

Loading…